📚 Introduction to Medical Biotechnology: A Comprehensive Study Guide

This study material is compiled from Chapter 11: Medical Biotechnology of "Introduction to Biotechnology, Fourth Edition, Global Edition" (Copyright © 2020 Pearson Education Ltd.) and an accompanying lecture audio transcript.

---

Overview of Medical Biotechnology

Medical biotechnology is a scientific field that leverages biological systems and living organisms for the prevention, diagnosis, and treatment of human diseases. This discipline offers revolutionary innovations with the potential to significantly improve human health. This guide will explore how diseases are understood and diagnosed, delve into modern therapeutic methods, and examine regenerative approaches shaping the future of medicine.

---

1. 🐾 Animal Models of Human Disease

Animal models are fundamental to understanding human diseases, especially because human genetics cannot be manipulated for experimental purposes.

1.1. Importance of Model Organisms

✅ Many human genetic diseases have counterparts in model organisms like mice, microscopic roundworms (Caenorhabditis Elegans), and fruit flies. 💡 Identifying key genes in these models helps form hypotheses and predictions about their function in humans. 🔬 Scientists use these models to: * Identify disease genes. * Test gene therapy and drug-based therapeutic approaches. * Conduct preclinical studies to assess effectiveness and safety before clinical trials.

1.2. Genetic Similarities

📚 Homologs: Genes in different species that are similar to human genes based on DNA sequence.

• Example: Ob Gene
  • Found in both mice and humans.
  • Codes for the protein leptin.
  • If the Ob gene is nonfunctional and leptin is not produced, both mice and humans become obese.

1.3. Diverse Model Organisms

• Caenorhabditis Elegans (Roundworm): Studies on genes involved in apoptosis (pre-programmed cell death) in this organism aid in understanding human neurodegenerative diseases.
• Fruit Flies: Genes determining human body plans, organ development, aging, and death are virtually identical to those in fruit flies.
  • 📊 61% of genes mutated in 289 human diseases are also found in fruit flies.

1.4. Advanced Modeling Techniques

• Gene Knockouts: Researchers use gene knockouts to create mouse models for human diseases.
  • Example: "Heart attack mice" deficient in certain genes required for cholesterol metabolism. These mice develop elevated blood cholesterol levels similar to those in atherosclerosis (hardening of the arteries), making them useful for testing heart disease therapies.
• Genome Editing:
  • 💡 CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated proteins): A significant tool for editing genes in model organisms to study various diseases.

---

2. 🔬 Detecting and Diagnosing Human Disease Conditions

Early detection is crucial for effective treatment and improving survival rates.

2.1. Biomarkers for Disease Detection

✅ Biomarkers: Typically proteins produced by diseased tissue or proteins whose production increases when a tissue is diseased.

• Example: PSA (prostate-specific antigen) for prostate cancer.
• Circulating Tumor DNA (ctDNA): Fragments of cancer cell genomes released into the bloodstream when tumor cells die. These can sometimes be detected by DNA sequencing.
• Protein Microarrays: Similar to DNA microarrays, these chips contain hundreds or thousands of antibodies spotted on them, used for disease detection.

2.2. Genomic Initiatives

• Human Genome Project: Revealed disease genes on all human chromosomes.
• The Cancer Genome Atlas Project (TCGA): A comprehensive effort stemming from the Human Genome Project to identify genomic changes involved in various cancers.

2.3. Detecting Genetic Diseases

2.3.1. Chromosome Abnormalities

• Down Syndrome (Trisomy 21): Three copies of chromosome 21. Its incidence is related to the age of the mother's eggs.
• Prenatal Diagnostic Methods:
  • Amniocentesis: Performed around 16 weeks of gestation. A sample of amniotic fluid is taken to create a karyotype (a picture of a person's chromosomes).
  • Chorionic Villus Sampling (CVS): Performed around 8–10 weeks of gestation. A small portion of the chorionic villus (which helps form the placenta) is removed to create a karyotype.
  • Noninvasive Prenatal Genetic Diagnosis (NIPD): Reduces risk to the fetus by analyzing cell-free fetal DNA from the mother's blood.
• Fluorescence In Situ Hybridization (FISH): A newer technique for karyotyping, useful for identifying missing or extra chromosomes, and easier for detecting defective chromosomes.
  • Spectral Karyotyping FISH: A variant useful for identifying missing and extra chromosomes.

2.3.2. Gene Mutations

• Most genetic diseases result from mutations in specific genes.
• RFLP (Restriction Fragment Length Polymorphism): A method to detect variations in DNA sequences.
• Allele-Specific Oligonucleotide Analysis (ASO): Allows detection of single nucleotide changes, even if the mutation doesn't alter a restriction site.
  • Example: Used in diagnosing sickle cell anemia.
• Preimplantation Genetic Testing (PGT) / Preimplantation Genetic Diagnosis (PGD):
  • Uses ASO, PCR, and FISH to screen for gene defects in single cells from 8- to 32-cell-stage embryos created by IVF.
  • Holds the largest share of the genetic testing market.

2.3.3. Single Nucleotide Polymorphisms (SNPs)

📚 SNPs: One of the most common forms of genetic variation among humans.

• Occur approximately every 100 to 300 base pairs in the human genome, accounting for about 90% of human genetic variation.
• If an SNP occurs in a gene sequence, it may cause a change in protein structure, leading to disease or influencing traits.
• Detection: DNA sequencing and ASO analysis.
• Prediction: Might be used to predict susceptibilities to conditions like stroke, diabetes, cancer, heart disease, and behavioral/emotional illnesses.

2.3.4. DNA Microarrays

• Also known as "gene chips," these are glass microscope slides spotted with DNA "probes" representing genes.
• Can screen a patient for a pattern of genes expressed in a particular disease condition.

---

3. 🧬 Sequence Analysis of Individual Genomes

The evaluation of a person's genetic information is rapidly evolving.

• Whole-Genome Sequencing (WGS): Sequences an entire genome.
• Whole-Exome Sequencing (WES): Sequences only the protein-coding regions (exons) of the genome.
  • 💡 The NIH's Undiagnosed Diseases Network uses WES and WGS to help diagnose rare diseases.
• Single-Cell Sequencing (SCS): Sequences the genome from a single cell, often requiring PCR amplification due to limited DNA.
• RNA Sequencing (RNAseq): A powerful tool for transcriptome-wide analysis of genes expressed by cells within a population, differentiating genetic variations.
  • Single-Cell RNA Sequencing (scRNA-seq): RNA sequencing applied to individual cells.
• Genome-Wide Association Studies (GWAS): Used to identify genetic variations associated with particular diseases.

---

4. 💊 Precision Medicine and Biotechnology

Precision medicine aims to tailor medical treatment to the individual characteristics of each patient.

4.1. The Search for New Medicines and Drugs

• Oncogenes: Genes involved in the growth of cancer cells.
• Tumor Suppressor Genes: Produce proteins that keep cancer formation in check.
• Researchers develop drugs that bind to these protein products to inhibit or activate their function as appropriate.

4.2. Pharmacogenomics for Personalized Medicine

📚 Pharmacogenomics: Designing the most effective drug therapy and treatment strategies based on a patient's specific genetic profile.

• Individuals react differently to the same drugs due to genetic polymorphisms, leading to varying effectiveness and side effects.
• Challenge: Chemotherapy targets rapidly dividing cells, affecting normal cells (hair, skin, bone marrow) and causing side effects.
• Goal: Develop "magic bullet" drugs that destroy only cancer cells without harming normal cells.
• Example: Breast Cancer
  • BRCA1 and BRCA2 genes can be involved in breast cancer.
  • Tissue from a breast tumor can be analyzed via SNP and microarray to determine which genes are involved.
  • This information guides the design of specific and effective drug treatment strategies.
• Example: Herceptin
  • Developed by Genentech, it's a monoclonal antibody that binds and inhibits HER-2.
  • HER-2 is overexpressed in 25-30% of breast cancer cases, leading to aggressive cancer with poorer prognosis.
  • Herceptin is effective in some women, but tumors can become resistant.
• Example: Gleevec
  • Introduced by Novartis in 2001 for chronic myelogenous leukemia (CML).
  • Targets the BCR-ABL fusion protein, formed by an exchange of DNA between chromosomes 9 and 22 in CML.
  • Proven to be a relatively effective treatment for CML.

4.3. Improved Drug Delivery

• Nanotechnology and Nanomedicine:
  • 📚 Nanotechnology: Designing, building, and manipulating structures at the nanometer scale (one-billionth of a meter).
  • Applications:
    • Maximize drug effectiveness (solubility, breakdown, elimination).
    • Nanomedicine: Applications to improve human health.
    • Nanodevices: Monitor blood pressure, oxygen levels, hormone concentrations.
    • Nanoparticles: Unclog arteries, detect and eliminate cancer cells.
    • "Smart drugs": Gold nanoparticles that seek out and target viruses or specific cells (e.g., cancer cells), delivering cargo rapidly and effectively with few side effects.
    • Microspheres: Tiny particles filled with drugs, made from lipid-like materials. Can be sprayed into the nose for lung cancer, respiratory illnesses, or used for anticancer drugs and pain management.

4.4. Vaccines and Therapeutic Antibodies

• Cancer Vaccines: Injected with cancer cell antigens to stimulate the immune system to attack cancer cells.
• Vaccines are also being developed for diseases like Alzheimer's.
• Monoclonal Antibodies (mAbs): Purified antibodies highly specific for certain molecules.
  • Applications: Treat cancer cells, arthritis, Alzheimer's disease, and addiction to harmful drugs.
  • Humanized Antibodies: Genetically engineered to increase their similarity to human antibodies, reducing immune rejection.
  • mAbs can be injected to seek out and target specific antigens (e.g., Olaratumab).

4.5. Immunotherapy

📚 Immunotherapy: Uses a patient's own immune system to attack and destroy diseased cells.

• Two main strategies:
  1. Chimeric Antigen Receptor (CAR)-T cells: T cells engineered to recognize specific cancer antigens.
  2. Recombinant T Cell Receptors (TCRs): Engineered to specifically recognize antigens on or within cancer cells.
• Immunotherapy has shown remarkable therapeutic effects in clinical trials, leading to long-lasting remission and tumor disappearance in some patients.

---

5. 🧬 Gene Therapy

📚 Gene Therapy: The delivery of therapeutic genes into the human body to correct disease conditions caused by faulty genes.

5.1. Core Questions

• How are genes delivered?
• How can genes be sent to the proper tissues and organs?
• Can it be effective and safe?

5.2. Strategies for Gene Delivery

1. Ex vivo gene therapy:
   • Cells are removed from the patient.
   • Treated with techniques similar to transformation (introducing foreign DNA).
   • Reintroduced to the patient.
   • 📚 Transfection: Introduction of DNA into animal or plant cells.
2. In vivo gene therapy:
   • Introducing genes directly into tissues and organs in the body.
   • ⚠️ Challenge: Delivering genes only to intended tissues, not throughout the body.

5.3. Vectors for Gene Delivery

5.3.1. Viral Vectors

• Rely on viruses to carry therapeutic genes. The virus infects human cells, introducing the gene.
• Common viral vectors: Adenovirus (common cold), Influenza virus (flu), Herpes virus (cold sores).
• ⚠️ Viruses must be genetically engineered to prevent disease and spread.
• How Viruses Infect Cells: Bind, enter, release genetic material (DNA/RNA), and use the host cell to reproduce viral components.
• Why Viruses Make Good Vectors:
  • Efficient at infecting many types of human cells.
  • Retroviruses (e.g., lentivirus, including HIV): Permanently insert their DNA into the host cell genome (integration), making them attractive for long-term gene expression.
  • Some viruses infect only specific cell types, which is good for targeted gene therapy.

5.3.2. Other Gene Delivery Options

• Naked DNA: DNA injected directly into body tissues. Only a small number of cells take it up.
• Liposomes: Small, hollow particles made of lipid molecules. They can be packaged with genes and injected or sprayed into tissues.

5.4. Gene Silencing Technologies

5.4.1. Antisense RNA Technology

• Blocks translation of mRNA molecules to silence gene expression.
• An RNA molecule complementary to the target mRNA binds to it, preventing translation.
• Also called RNA silencing or gene silencing.
• Promising for turning off disease genes, but its therapeutic potential is still being realized.

5.4.2. RNA Interference (RNAi)

1. Double-stranded RNA molecules are delivered into cells.
2. The enzyme Dicer chops them into 21-nucleotide-long pieces called small interfering RNAs (siRNAs).
3. siRNAs join with the RNA-induced silencing complex (RISC).
4. RISC shuttles siRNAs to their target mRNA, where they bind.
5. siRNA-bound mRNAs are degraded, preventing translation into protein.

5.5. Genome or Gene Editing

📚 Genome/Gene Editing: Approaches designed to precisely modify specific genes in the genome.

• Tools:
  • Zinc-finger nucleases (ZFNs)
  • TALENS (transcription activator-like effector nucleases)
  • CRISPR-Cas: Delivers a single-stranded "guided" RNA sequence (sgRNA) complementary to the target gene, attached to the endonuclease Cas9.
• Examples:
  • AAV delivery of CRISPR-Cas9 to remove a defective exon from the Dmd gene in a mouse model of Duchenne muscular dystrophy (DMD) significantly restored muscle function.
  • Used to target and replace the defective clotting Factor IX gene in liver cells to cure mice of hemophilia B.

5.6. Milestones and Applications

• First Human Gene Therapy (1990): Treated a SCID (severe combined immunodeficiency) patient.
  • SCID is caused by a defect in the adenosine deaminase (ADA) gene, leading to toxic dATP accumulation and T-cell deficiency.
• Gene Therapy for Blindness:
  • Leber’s Congenital Amaurosis (LCA): Targets the RPE65 gene, whose protein metabolizes retinol (a form of vitamin A essential for light detection). Injections of the normal gene via AAV have improved vision in some patients.
  • Choroideremia: Another form of blindness targeted by gene therapy.

5.7. Challenges Facing Gene Therapy

• ⚠️ Potential risks of viral vectors:
  • Deaths of Jesse Gelsinger (1999, adenovirus) and two children in France (2002) led to temporary cessation of trials and increased patient monitoring.
• Unanswered Questions:
  • Can gene expression be controlled effectively?
  • Can we safely and efficiently target only the necessary cells?
  • How can gene therapy be targeted to specific genomic regions?
  • How long will the therapy last?
  • Will the immune system reject the therapy?
  • How many cells need to be corrected for therapeutic effect?

---

6. 🌱 The Potential of Regenerative Medicine

Regenerative medicine aims to grow cells and tissues to replace or repair defective tissues and organs, moving beyond traditional treatments like surgery, radiation, and drug therapy.

6.1. Cell and Tissue Transplantation

6.1.1. Fetal Tissue Grafts

• Fetal neurons can divide and repair themselves, unlike adult neurons.
• Potential treatment for neurodegenerative diseases and spinal cord injuries by replacing damaged brain cells.
• Example: Parkinson's disease patients have shown symptom improvement (40%) and occasional complete reversal.
• ⚠️ Controversy: Human fetal tissue comes from embryos/fetuses from accident victims or legally aborted embryos.

6.1.2. Organ Transplantation

• Autografting: Transplantation of a patient's own tissue from one body region to another (e.g., coronary artery bypass). Alleviates some transplantation problems.
• Donor Organs: From other human donors, but organ rejection is a major problem.
  • Tissue typing must match Major Histocompatibility Complex (MHC) proteins between donor and recipient.
  • Recipients require immunosuppressive drugs, which weaken their immune systems.
• Xenotransplantation: Transfer of organs from different species.
  • May become a viable alternative to human-to-human donation, addressing organ shortages.
  • Pigs: Good choice due to abundance, ease of breeding, and similar organ function/size.
  • Researchers use molecular methods to produce cloned, genome-edited pigs to overcome rejection and viral transmission fears.

6.1.3. Cellular Therapeutics

• Uses cells to replace defective tissues or deliver biological molecules.
• Donor or genetically engineered cells can be encapsulated in biocapsules.
  • These have tiny holes, allowing nutrient exchange and release of cell products.
  • Protect cells from the host immune system.

6.2. Tissue Engineering

• Provides tissues and organs to replace damaged or diseased ones.
• Process:
  1. 1️⃣ Design a framework or scaffold.
  2. 2️⃣ Seed the scaffold with human cells.
  3. 3️⃣ Bathe in nutrient-rich media.
  • Cells build layers and assume the scaffold's shape.
• Examples:
  • Sheets of skin grafts.
  • "Engineered ear" on a mouse's back (Dr. Charles Vacanti, 1990s) – seeded with cow cells, only outer ear structure.
  • Human bladders, rudimentary kidneys.
• 3D Bioprinting:
  • Sprays cells in solution (like ink pigments) through inkjet-like nozzles onto a scaffold.
  • Layer by layer, cells are precisely positioned to create 3D tissue and organ structures.
• Organoids: Miniature organs produced from stem cells and grown in culture.
  • Can be used in "organs-on-chips" for research and drug testing.

6.3. Stem Cells

📚 Stem Cells: Undifferentiated cells with the ability to self-renew and differentiate into specialized cell types.

6.3.1. Human Embryonic Stem Cells (hESCs)

• Derived from the inner cell mass of a blastocyst (an early-stage embryo).
• Possess pluripotency: The ability to differentiate into all 200+ cell types in the human body.
• Sources:
  • Embryos leftover from in vitro fertilization (IVF).
  • Embryos created by IVF specifically for research.
• Characteristics:
  • Can self-renew indefinitely to produce more stem cells.
  • Can be maintained as cell lines in culture.
  • Can be stimulated for directed differentiation into specific cell types, which is key for regenerative medicine.
• Research Focus: Understanding pluripotency and identifying factors that stimulate differentiation into discrete cell types.